Satellos Bioscience Inc. — Capital/Financing Update 2026

Feb 6, 2026

{0}------------------------------------------------

200 Bay Street, South Tower Suite 2800 Toronto, ON 647 499 2828 mintz.com

February 5, 2026

VIA SEDAR+

Ontario Securities Commission, as principal regulator British Columbia Securities Commission Alberta Securities Commission

Dear Sirs/Mesdames:

Re: Satellos Bioscience Inc. - Prospectus Supplement dated February 5, 2026 to the Short Form Base Shelf Prospectus dated October 29, 2025 (the "Prospectus Supplement")

We hereby consent to the reference to our name on the face page and under the headings "Documents Filed as Part of the Registration Statement" and "Legal Matters & Interest of Experts" and the use of our opinions under the headings "Eligibility for Investment" and "Certain Canadian Federal Income Tax Considerations" in the Prospectus Supplement relating to the offering of common shares and pre-funded warrants of Satellos Bioscience Inc.

We have read the Prospectus Supplement and have no reason to believe that there are any misrepresentations in the information contained in the Prospectus Supplement that are within our knowledge as a result of services we performed in connection with the Prospectus Supplement.

Yours truly,

(signed) "Mintz LLP"